LEVERNA
Live / Applied — Fifth extension granted (statement of use) (as of 27 Aug 2025)
What this means for you
Not registered yet, but its 27 May 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97432424
- Mark type
- Stylized text
- Filed
- 27 May 2022
- Published for opposition
- 10 Jan 2023
- Attorney of record
- Perry Gattegno
Goods and services
- Class 042 — Scientific and technological services: Biochemical research and development; Biotechnology research; Pharmaceutical drug development services; Pharmaceutical products development; Pharmaceutical research and development; Research and development in the pharmaceutical and biotechnology fields; Research and development in the field of RNA-targeted drugs; Research and development in the field of nucleic acids, biologics, central nervous system diseases, metabolic diseases, and small molecule drugs; Research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines; Testing, inspection, research, or development of pharmaceutical preparations for gene therapy
Owner
- Fosun Pharma USA Inc., Princeton, NJ, US
- Fosun Pharma USA Inc., Princeton, NJ, US
Prosecution history
- 27 Aug 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 27 Aug 2025 — SOU EXTENSION 5 GRANTED
- 17 Aug 2025 — SOU EXTENSION 5 FILED
- 18 Aug 2025 — SOU TEAS EXTENSION RECEIVED
- 25 Feb 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 25 Feb 2025 — SOU EXTENSION 4 GRANTED
- 24 Feb 2025 — SOU EXTENSION 4 FILED
- 24 Feb 2025 — SOU TEAS EXTENSION RECEIVED
- 27 Aug 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 27 Aug 2024 — SOU EXTENSION 3 GRANTED
- 27 Aug 2024 — SOU EXTENSION 3 FILED
- 27 Aug 2024 — SOU TEAS EXTENSION RECEIVED
- 07 Feb 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 05 Feb 2024 — SOU EXTENSION 2 GRANTED
- 05 Feb 2024 — SOU EXTENSION 2 FILED